ImmunoMind
PrivateLast Round
Accelerator
Sep 15, 2020
Total Funding Raised
$105,000
Company Overview
ImmunoMind operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was an Accelerator round in September 2020.
ImmunoMind is a biotechnology company that provides an open-source ecosystem for designing personalized immunotherapies and vaccines using systems immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoMind Comparables
Compare ImmunoMind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ozette | 84% | |
| ENPICOM | 78% | |
| Scailyte AG | 77% |
For institutional investors. Book with your work email.
ImmunoMind Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 1370% MoM.
- Sep 15, 2020
$105K raised led by SkyDeck.
For institutional investors. Book with your work email.
ImmunoMind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmunoMind's valuation, stock price, and market status.
Is ImmunoMind a public or private company?
ImmunoMind is a private company.
What is the current stock price of ImmunoMind?
ImmunoMind is a private company, so its shares have no public market price. Caplight tracks ImmunoMind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmunoMind worth (valuation)?
Valuation information for ImmunoMind is not publicly available.
Can I buy ImmunoMind stock?
ImmunoMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmunoMind's last funding round?
ImmunoMind's most recent funding round was Accelerator on September 15, 2020.
Who are the main investors in ImmunoMind?
Investor information for ImmunoMind is not publicly disclosed.
Will ImmunoMind IPO soon?
No public IPO plans have been announced for ImmunoMind.
How can I track ImmunoMind secondary market activity?
Caplight tracks bids, offers, and trades in ImmunoMind's shares on secondary markets.